1. HLA-A∗0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins
- Author
-
Yuh-Cheng Yang, Jian-Yu Lin, Show-Li Chen, Chih-Hsiang Leng, Yeou-Ping Tsao, Jia-Tsrong Jan, and Chen-Chung Chu
- Subjects
Molecular Sequence Data ,Biophysics ,Epitopes, T-Lymphocyte ,Peptide binding ,Spike ,SARS virus ,Mice, Transgenic ,Human leukocyte antigen ,Biology ,medicine.disease_cause ,Major histocompatibility complex ,Severe Acute Respiratory Syndrome ,Biochemistry ,Epitope ,Article ,Mice ,CTL epitope ,Capsid ,Th2 Cells ,Antigen ,Viral Envelope Proteins ,HLA-A2 Antigen ,medicine ,Animals ,Coronavirus Nucleocapsid Proteins ,Humans ,Nucleocapsid ,Molecular Biology ,Coronavirus ,Membrane Glycoproteins ,HLA-A Antigens ,Immunogenicity ,Viral Vaccines ,Cell Biology ,DNA ,Nucleocapsid Proteins ,Virology ,HLA-A∗0201 ,CTL ,Oligodeoxyribonucleotides ,Severe acute respiratory syndrome-related coronavirus ,Immunology ,Spike Glycoprotein, Coronavirus ,biology.protein ,Leukocytes, Mononuclear ,Peptides ,T-Lymphocytes, Cytotoxic - Abstract
The immunogenicity of HLA-A*0201-restricted cytotoxic T lymphocyte (CTL) peptide in severe acute respiratory syndrome coronavirus (SARS-CoV) nuclear capsid (N) and spike (S) proteins was determined by testing the proteins' ability to elicit a specific cellular immune response after immunization of HLA-A2.1 transgenic mice and in vitro vaccination of HLA-A2.1 positive human peripheral blood mononuclearcytes (PBMCs). First, we screened SARS N and S amino acid sequences for allele-specific motif matching those in human HLA-A2.1 MHC-I molecules. From HLA peptide binding predictions (http://thr.cit.nih.gov/molbio/hla_bind/), ten each potential N- and S-specific HLA-A2.1-binding peptides were synthesized. The high affinity HLA-A2.1 peptides were validated by T2-cell stabilization assays, with immunogenicity assays revealing peptides N223-231, N227-235, and N317-325 to be the first identified HLA-A*0201-restricted CTL epitopes of SARS-CoV N protein. In addition, previous reports identified three HLA-A*0201-restricted CTL epitopes of S protein (S978-986, S1203-1211, and S1167-1175), here we found two novel peptides S787-795 and S1042-1050 as S-specific CTL epitopes. Moreover, our identified N317-325 and S1042-1050 CTL epitopes could induce recall responses when IFN-gamma stimulation of blood CD8+ T-cells revealed significant difference between normal healthy donors and SARS-recovered patients after those PBMCs were in vitro vaccinated with their cognate antigen. Our results would provide a new insight into the development of therapeutic vaccine in SARS.
- Published
- 2006